Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

68.24
Delayed Data
As of Dec 09
 -0.33 / -0.48%
Today’s Change
26.26
Today|||52-Week Range
69.80
+76.42%
Year-to-Date
AstraZeneca (AZN) Presents Tagrisso Data at Medical Meeting
Dec 07 / Zacks.com - Paid Partner Content
Ultragenyx (RARE) Reports Positive Phase II Study on UX007
Dec 01 / Zacks.com - Paid Partner Content
Juno Reports Positive Phase I Study Data on Lymphoma Drug
Dec 06 / Zacks.com - Paid Partner Content
Achillion, J&J to Initiate Phase IIb Study on HCV Combo
Dec 01 / Zacks.com - Paid Partner Content
Pfizer (PFE) Presents Favorable Data on Leukemia Candidate
Dec 05 / Zacks.com - Paid Partner Content
Time to Focus on Heska (HSKA) for Strong Earnings Growth Potential
Nov 30 / Zacks.com - Paid Partner Content
Pfizer Offers Positive Phase III Data on Pediatric Epilesy Drug
Dec 02 / Zacks.com - Paid Partner Content
Valeant (VRX) Ups Sales Force to Support Xifaxan/Relistor
Nov 30 / Zacks.com - Paid Partner Content
AbbVie Crohn's Disease Drug Gets Orphan Drug Status in U.S.
Dec 01 / Zacks.com - Paid Partner Content
Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth
Nov 29 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close68.57
Today’s open68.86
Day’s range67.86 - 69.75
Volume53,234
Average volume (3 months)101,496
Market cap$473.0M
Dividend yield0.59%
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+80.49%
Earnings growth (this year)+80.89%
Earnings growth (next 5 years)+27.85%
Revenue growth (last year)+16.43%
P/E ratio54.6
Price/Sales2.62
Price/Book7.15

Competitors

 Today’s
change
Today’s
% change
COLLCollegium Pharmaceut...+0.32+2.01%
RETAReata Pharmaceutical...-0.27-1.25%
VSARVersartis Inc-0.20-1.50%
CYTKCytokinetics Inc-0.05-0.44%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)$0.36
Annual revenue (last year)$104.6M
Annual profit (last year)$5.2M
Net profit margin5.01%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin S. Wilson
Secretary, Chief Operating &
Strategist Officer
Jason A. Napolitano
Corporate headquarters
Loveland, Colorado

Forecasts


Search for Jobs